149 related articles for article (PubMed ID: 2754695)
1. Minimum-structure enkephalin analogues incorporating L-tyrosine, D(or L)-phenylalanine, and a diamine spacer.
Jacobson AR; Gintzler AR; Sayre LM
J Med Chem; 1989 Aug; 32(8):1708-17. PubMed ID: 2754695
[TBL] [Abstract][Full Text] [Related]
2. Dermorphin tetrapeptide analogues with 2',6'-dimethylphenylalanine (Dmp) substituted for aromatic amino acids have high mu opioid receptor binding and biological activities.
Ambo A; Niizuma H; Sasaki A; Kohara H; Sasaki Y
Bioorg Med Chem Lett; 2003 Apr; 13(7):1269-72. PubMed ID: 12657261
[TBL] [Abstract][Full Text] [Related]
3. Minimum structure opioids-dipeptide and tripeptide analogs of the enkephalins.
Vavrek RJ; Hsi LH; York EJ; Hall ME; Stewart JM
Peptides; 1981; 2(3):303-8. PubMed ID: 6272246
[TBL] [Abstract][Full Text] [Related]
4. Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity.
Schiller PW; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Marsden BJ; Wilkes BC
J Med Chem; 1991 Oct; 34(10):3125-32. PubMed ID: 1656045
[TBL] [Abstract][Full Text] [Related]
5. Cyclic enkephalin analogs containing various para-substituted phenylalanine derivatives in place of Tyr1 are potent opioid agonists.
Weltrowska G; Lemieux C; Chung NN; Schiller PW
J Pept Res; 2005 Jan; 65(1):36-41. PubMed ID: 15686532
[TBL] [Abstract][Full Text] [Related]
6. Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
Mosberg HI; Lomize AL; Wang C; Kroona H; Heyl DL; Sobczyk-Kojiro K; Ma W; Mousigian C; Porreca F
J Med Chem; 1994 Dec; 37(25):4371-83. PubMed ID: 7996549
[TBL] [Abstract][Full Text] [Related]
7. Dicarba analogues of the cyclic enkephalin peptides H-Tyr-c[D-Cys-Gly-Phe-D(or L)-Cys]NH(2) retain high opioid activity.
Berezowska I; Chung NN; Lemieux C; Wilkes BC; Schiller PW
J Med Chem; 2007 Mar; 50(6):1414-7. PubMed ID: 17315860
[TBL] [Abstract][Full Text] [Related]
8. Development of a model for the delta opioid receptor pharmacophore. 2. Conformationally restricted Phe3 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
Mosberg HI; Omnaas JR; Lomize A; Heyl DL; Nordan I; Mousigian C; Davis P; Porreca F
J Med Chem; 1994 Dec; 37(25):4384-91. PubMed ID: 7996550
[TBL] [Abstract][Full Text] [Related]
9. Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists.
Schiller PW; Nguyen TM; Weltrowska G; Wilkes BC; Marsden BJ; Lemieux C; Chung NN
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11871-5. PubMed ID: 1334552
[TBL] [Abstract][Full Text] [Related]
10. Novel ligands lacking a positive charge for the delta- and mu-opioid receptors.
Schiller PW; Berezowska I; Nguyen TM; Schmidt R; Lemieux C; Chung NN; Falcone-Hindley ML; Yao W; Liu J; Iwama S; Smith AB; Hirschmann R
J Med Chem; 2000 Feb; 43(4):551-9. PubMed ID: 10691681
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers.
Schiller PW; Nguyen TM; Lemieux C; Maziak LA
J Med Chem; 1985 Dec; 28(12):1766-71. PubMed ID: 2999401
[TBL] [Abstract][Full Text] [Related]
12. Conformationally restricted deltorphin analogues.
Schiller PW; Weltrowska G; Nguyen TM; Wilkes BC; Chung NN; Lemieux C
J Med Chem; 1992 Oct; 35(21):3956-61. PubMed ID: 1331451
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological characterization in vitro of cyclic enkephalin analogues: effect of conformational constraints on opiate receptor selectivity.
DiMaio J; Nguyen TM; Lemieux C; Schiller PW
J Med Chem; 1982 Dec; 25(12):1432-8. PubMed ID: 6296388
[TBL] [Abstract][Full Text] [Related]
14. Potent morphiceptin analogs: structure activity relationships and morphine-like activities.
Chang KJ; Wei ET; Killian A; Chang JK
J Pharmacol Exp Ther; 1983 Nov; 227(2):403-8. PubMed ID: 6313901
[TBL] [Abstract][Full Text] [Related]
15. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of stable and potent delta/mu opioid peptides: analogues of H-Tyr-c[D-Cys-Gly-Phe-D-Cys]-OH by ring-closing metathesis.
Mollica A; Guardiani G; Davis P; Ma SW; Porreca F; Lai J; Mannina L; Sobolev AP; Hruby VJ
J Med Chem; 2007 Jun; 50(13):3138-42. PubMed ID: 17539621
[TBL] [Abstract][Full Text] [Related]
17. Effects of changes in the structure of enkephalins and of narcotic analgesic drugs on their interactions with mu- and delta-receptors.
Kosterlitz HW; Lord JA; Paterson SJ; Waterfield AA
Br J Pharmacol; 1980 Feb; 68(2):333-42. PubMed ID: 6101980
[TBL] [Abstract][Full Text] [Related]
18. Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.
Schmidt R; Vogel D; Mrestani-Klaus C; Brandt W; Neubert K; Chung NN; Lemieux C; Schiller PW
J Med Chem; 1994 Apr; 37(8):1136-44. PubMed ID: 8164255
[TBL] [Abstract][Full Text] [Related]
19. [Cys(O2NH2)2]enkephalin analogues and dalargin: selectivity for delta-opioid receptors.
Pencheva N; Bocheva A; Dimitrov E; Ivancheva C; Radomirov R
Eur J Pharmacol; 1996 May; 304(1-3):99-108. PubMed ID: 8813590
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of highly mu and delta opioid receptor selective peptides containing a photoaffinity group.
Landis G; Lui G; Shook JE; Yamamura HI; Burks TF; Hruby VJ
J Med Chem; 1989 Mar; 32(3):638-43. PubMed ID: 2537426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]